Literature DB >> 29892476

Ambulatory Intra Aortic Balloon Pump in Advanced Heart Failure.

Syed Yaseen Naqvi1, Ibrahim G Salama2, Ayhan Yoruk1, Leway Chen1.   

Abstract

Cardiac transplantation is the gold standard treatment for patients with advanced congestive heart failure that is refractory to maximal medical therapy. However, donor heart availability remains the major limiting factor, resulting in a large number of patients waiting long periods of time before transplantation. As a result, mechanical circulatory support devices have been increasingly used as a 'bridge' in order to sustain organ function and stabilise haemodynamics while patients remain on the transplant waiting list or undergo left ventricular assist device surgery. Intra aortic balloon pumps (IABP) are commonly used for temporary circulatory support in patients with advanced heart failure. IABP is traditionally placed percutaneously through the transfemoral artery approach. The major limitation with this approach is ambulatory restriction that can promote deconditioning, particularly in situations of prolonged circulatory support. A subclavian/axillary artery approach IABP insertion allows patients to be ambulatory during the pre-transplant period. In this review, we aim to summarise the physiology of IABP, the evidence for its use in advanced CHF and the efficacy and safety of subclavian artery IABP insertion.

Entities:  

Keywords:  Intra aortic balloon pump; advanced heart failure; cardiac transplantation; left ventricular assist device; mechanical circulatory support; subclavian artery intra aortic balloon pump

Year:  2018        PMID: 29892476      PMCID: PMC5971668          DOI: 10.15420/cfr.2018:22:1

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN: 2057-7540


  35 in total

1.  Visceral arterial compromise during intra-aortic balloon counterpulsation therapy.

Authors:  Ardawan Julian Rastan; Eugen Tillmann; Sreekumar Subramanian; Lukas Lehmkuhl; Anne Kathrin Funkat; Sergej Leontyev; Torsten Doenst; Thomas Walther; Matthias Gutberlet; Friedrich Wilhelm Mohr
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

2.  Extended duration of brachially inserted intra-aortic balloon pump for myocardial protection in two patients undergoing urgent coronary artery bypass grafting.

Authors:  Shantu Bundhoo; Peter A O'Keefe; Heyman Luckraz; Nick Ossei-Gerning
Journal:  Interact Cardiovasc Thorac Surg       Date:  2007-11-28

3.  Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium.

Authors:  E A Pomfret; R S Sung; J Allan; M Kinkhabwala; J K Melancon; J P Roberts
Journal:  Am J Transplant       Date:  2008-02-05       Impact factor: 8.086

4.  Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial.

Authors:  S Scheidt; G Wilner; H Mueller; D Summers; M Lesch; G Wolff; J Krakauer; M Rubenfire; P Fleming; G Noon; N Oldham; T Killip; A Kantrowitz
Journal:  N Engl J Med       Date:  1973-05-10       Impact factor: 91.245

5.  Subclavian artery approach for insertion of intra-aortic balloon.

Authors:  J H Mayer
Journal:  J Thorac Cardiovasc Surg       Date:  1978-07       Impact factor: 5.209

6.  Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).

Authors:  Randall C Starling; Yoshifumi Naka; Andrew J Boyle; Gonzalo Gonzalez-Stawinski; Ranjit John; Ulrich Jorde; Stuart D Russell; John V Conte; Keith D Aaronson; Edwin C McGee; William G Cotts; David DeNofrio; Duc Thinh Pham; David J Farrar; Francis D Pagani
Journal:  J Am Coll Cardiol       Date:  2011-05-10       Impact factor: 24.094

7.  Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.

Authors:  Joseph G Rogers; Keith D Aaronson; Andrew J Boyle; Stuart D Russell; Carmelo A Milano; Francis D Pagani; Brooks S Edwards; Soon Park; Ranjit John; John V Conte; David J Farrar; Mark S Slaughter
Journal:  J Am Coll Cardiol       Date:  2010-04-27       Impact factor: 24.094

8.  The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina.

Authors:  D O Williams; K S Korr; H Gewirtz; A S Most
Journal:  Circulation       Date:  1982-09       Impact factor: 29.690

9.  Intra-aortic balloon counterpulsation in decompensated cardiomyopathy patients: bridge to transplantation or assist device.

Authors:  Ieva Norkiene; Donata Ringaitiene; Kestutis Rucinskas; Robertas Samalavicius; Alis Baublys; Saulius Miniauskas; Vytautas Sirvydis
Journal:  Interact Cardiovasc Thorac Surg       Date:  2006-11-21

10.  Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation.

Authors:  Jerry D Estep; Andrea M Cordero-Reyes; Arvind Bhimaraj; Barry Trachtenberg; Nashwa Khalil; Matthias Loebe; Brian Bruckner; Carlos M Orrego; Jean Bismuth; Neal S Kleiman; Guillermo Torre-Amione
Journal:  JACC Heart Fail       Date:  2013-09-11       Impact factor: 12.035

View more
  3 in total

1.  Intra-Aortic Balloon Pump Catheter Insertion Using a Novel Left External Iliac Artery Approach in A Case of Chronic Heart Failure Due to Dilated Cardiomyopathy.

Authors:  Mirosław Dziekiewicz; Marek Banaszewski; Mateusz Kuć; Janina Stępińska
Journal:  Am J Case Rep       Date:  2019-12-07

2.  Commentary: Futility in the age of modern mechanical circulatory support.

Authors:  Alexander Schutz; Ravi Ghanta
Journal:  JTCVS Open       Date:  2020-06-29

Review 3.  Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices.

Authors:  Carlos A Labarrere; Ali E Dabiri; Ghassan S Kassab
Journal:  Front Bioeng Biotechnol       Date:  2020-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.